A powerful example of SBT-100′s inhibitory and anti-inflammatory ability is also demonstrated by its ability to block the effect of IL-6 on cancer cells and normal cells in vitro (Figure 5) by preventing STAT3 from transcribing target genes in the nucleus such as VEGF and PD-L1. This evidence concerns the gene VEGFA and cancer.